Screening
Screening
10/06/2020
The American Thoracic Society has released a scientific statement addressing disparities in lung cancer screening eligibility and focusing on barriers to screening and strategies to improve screening rates...
10/06/2020
Cardiometabolic risk
Cardiometabolic risk
08/31/2020
Focusing on body mass index over genetics could be vital for identifying individuals with the greatest risk of developing diabetes, according to researchers at ESC Congress 2020.
08/31/2020
prediabetes
prediabetes
07/21/2020
While cinnamon has been shown to have glucose-lowering properties, whether these could be employed in patients with prediabetes to prevent disease progression is unknown.
07/21/2020
Diabetes Q&A
Diabetes Q&A
05/20/2020
In a recent cohort study, researcher examined the risk of serious renal events associated with the use of sodium-glucose co-transporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors.
05/20/2020
Diabetes Q&A
Diabetes Q&A
04/06/2020
In a recent study, researchers investigated the possibility of using grip strength tests in the screening of patients for type 2 diabetes mellitus.
04/06/2020
Type 2 Diabetes
Type 2 Diabetes
03/23/2020
In an analysis of 3 placebo‐controlled, randomized, Phase 3 studies of a selective SGLT2 inhibitor, researchers observed clinically meaningful decreases in glycated HbA1c, fasting plasma glucose, and more...
03/23/2020
FDA
FDA
03/19/2020
The new safety labeling changes approved by the FDA address the use of SGLT2 inhibitors prior to surgery.
03/19/2020
Diabetes Q&A
Diabetes Q&A
03/18/2020
Findings from a retrospective new-user cohort study of female Medicare beneficiaries aged 65 years or older shed light on whether insulin glargine use is associated with increased breast cancer risk...
03/18/2020
Type 2 Diabetes
Type 2 Diabetes
02/11/2020
In a randomized controlled trial, researchers investigated whether this sodium-glucose cotransporter 2 inhibitor could reduce liver fat content among patients with recent-onset and metabolically...
02/11/2020
FDA
FDA
02/05/2020
The US Food and Drug Administration has released laboratory results of metformin products tested for N-Nitrosodimethylamine.
02/05/2020